Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence

Breast Cancer Research and Treatment

Volumn 117, Issue 2, 2009, Pages 365-370

  Yerushalmi, Rinat ^a   Kennecke, Hagen ^a   Woods, Ryan ^a   Olivotto, Ivo A ^b   Speers, Caroline ^a   Gelmon, Karen A ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b AIDS Vancouver Island   (Canada)

Author keywords

Contralateral; Metachronous; Multicenter; Multifocal; Survival breast cancer

Indexed keywords

AROMATASE INHIBITOR; MEGESTROL ACETATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PROGNOSIS;

EID: 68949106080     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0265-1     Document Type: Article

References (29)

1. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials Lancet 365 1687 1717
2. AA Fracchia PI Borgen 1991 Bilateral breast cancer Semin Surg Oncol 7 300 305 10.1002/ssu.2980070513
3. LA Newman AA Sahin JE Cunningham 2001 Case-control study of unilateral and bilateral breast carcinoma patients Cancer 91 1845 1853 10.1002/1097- 0142(20010515)91:10<1845::AID-CNCR1205>3.0.CO;2-Z
4. PJ Dawson 1996 Bilateral and multifocal breast cancer Cancer Control 3 258 266
5. IA Olivotto D Mates L Kan 1999 Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the screening mammography program of British Columbia Breast Cancer Res Treat 54 73 81 10.1023/A:1006152918283
6. L Scrucca A Santucci F Aversa 1999 Competing risk analysis using R: an easy guide for clinicians Bone Marrow Transplant 40 381 387 10.1038/sj.bmt. 1705727
7. JM Satagopan L Ben-Porat M Berwick 2004 A note on competing risks in survival data analysis Br J Cancer 91 1229 1235 10.1038/sj.bjc.6602102
8. ME Robson PO Chappuis J Satagopan 2004 A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment Breast Cancer Res 6 R8 R17 10.1186/bcr658
9. HT Kim 2007 Cumulative incidence in competing risks data and competing risks regression analysis Clin Cancer Res 13 559 565 10.1158/1078-0432.CCR-06- 1210
10. RJ Gray 1988 Class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1141 1154 10.1214/aos/1176350951
11. JP Fine RJ Gray 1999 Proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 496 509 10.2307/2670170
12. L Bertelsen L Bernstein JH Olsen 2008 Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the women's environment, cancer and radiation epidemiology study J Natl Cancer Inst 100 32 40 10.1093/jnci/djm267
13. NJ Coombs J Boyages 2005 Multifocal and multicentric breast cancer: does each focus matter? J Clin Oncol 23 7497 7502 10.1200/JCO.2005.02.1147
14. Schaapveld M, Visser O, Louwman WJ (2007) The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat 110:189-197. doi: 10.1007/s10549-007-9709-2
15. WH Kuo AM Yen PH Lee 2006 Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan Breast Cancer Res Treat 99 221 228 10.1007/s10549-006-9194-z
16. B Fowble A Hanlon G Freedman 2001 Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk Int J Radiat Oncol Biol Phys 51 679 690 10.1016/S0360-3016(01)01665-0
17. CK Gajalakshmi V Shanta M Hakama 1998 Risk factors for contralateral breast cancer in Chennai (Madras), India Int J Epidemiol 27 743 750 10.1093/ije/27.5.743
18. P Broet A de la Rochefordiere SM Scholl 1995 Contralateral breast cancer: annual incidence and risk parameters J Clin Oncol 13 1578 1583
19. JL Bernstein WD Thompson N Risch 1992 Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer Am J Epidemiol 136 925 936
20. J Kollias IO Ellis CW Elston 2001 Prognostic significance of synchronous and metachronous bilateral breast cancer World J Surg 25 1117 1124
21. RE Fechner 1972 Infiltrating lobular carcinoma without lobular carcinoma in situ Cancer 29 1539 1545
22. RS du Toit AP Locker IO Ellis 1989 Invasive lobular carcinomas of the breast-the prognosis of histopathological subtypes Br J Cancer 60 605 609
23. D DiCostanzo PP Rosen I Gareen 1990 Prognosis in infiltrating lobular carcinoma. An analysis of "classical" and variant tumors Am J Surg Pathol 14 12 23 10.1097/00000478-199001000-00002
24. J Ji K Hemminki 2007 Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology Breast Cancer Res Treat 105 229 236 10.1007/s10549-006-9445-z
25. AM Chen F Meric-Bernstam KK Hunt 2005 Breast conservation after neoadjuvant chemotherapy Cancer 103 689 695 10.1002/cncr.20815
26. B Chua O Ung R Taylor 2001 Frequency and predictors of axillary lymph node metastases in invasive breast cancer ANZ J Surg 71 723 728 10.1046/j.1445-1433.2001.02266.x
27. AA Andea D Bouwman T Wallis 2004 Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma Cancer 100 20 27 10.1002/cncr.11880
28. AA Andea T Wallis LA Newman 2002 Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma Cancer 94 1383 1390
29. JK Litton Y Eralp AM Gonzalez-Angulo 2007 Multifocal breast cancer in women ≤35 years old Cancer 110 1445 1450 10.1002/cncr.22928